The Microlife 3AC1: an accurate blood pressure measurement device in pregnancy and pre-eclampsia A. de Greeff, F. Reggiori, J. Anthony, A. Shennan, 2006 Introduction As one of the most commonly performed screening tests in pregnancy, accurate blood pressure measurement is vitally important to the diagnosis and management of hypertensive disorders in pregnancy. Few automated devices have been assessed for their accuracy in this population according to a recognized protocol. None of the devices, which achieved sufficient accuracy in pregnancy, were accurate in pre-eclampsia, except for one (device for self-measurement). We

Accuracy validation of the Microlife 3AS1-2 blood pressure device in a pregnant population with low blood pressure Hannah L. Nathan, Annemarie de Greeff, Natasha L. Hezelgrave, Lucy C. Chappell and Andrew H. Shennan Objective To assess the accuracy of the Microlife 3AS1-2 blood pressure (BP) device in pregnant women with low BP to investigate suitability for hypotensive detection in lowincome and middle-income countries. Conclusions According to the BHS protocol, the Microlife 3AS1-2 BP device is accurate in pregnant women with low BP. The device has been validated previously in pregnancy and

Rapid Assessment of Blood Pressure in the Obstetric Day Unit Using Microlife MAM Technology Anja Wilton, Annemarie De Greef, and Andrew Shennan, 2006 Abstract Rapid Assessment of Blood Pressure in the Obstetric Day Unit Using Microlife MaM Technology Maternal and Fetal Health Research Unit, Division of Reproduction and Endocrinology, King’s College London School of Medicine at Guy’s, King’s College and St. Thomas’ Hospital, London, UK Objective To compare MAM technology with current methods of assessing blood pressure (BP) over time on the obstetric day unit. Background: It

Validation and Compliance of a Home Monitoring Device in Pregnancy: Microlife WatchBP Home Chung Y., de Greeff A., Shennan A., 2009; 28: 348-59. Objective To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting. Results The device achieved a mean difference ± SD of 0.4 ± 7.3/ −0.4 ± 5.5 mmHg (pregnancy) and −2.6 ± 7.0/0.8 ± 4.4 mmHg (preeclampsia) for systolic/ diastolic pressure. Eighty-one percent of women did at least 6 measurements/day and all women did at least

An accurate semiautomated oscillometric blood pressure device for use in pregnancy (including pre-eclampsia) in a low-income and middle-income country population: the Microlife 3AS1-2, Nathan, 2014. Hannah L. Nathan, Annemarie de Greeff, Natasha L. Hezelgrave, Lucy C. Chappell and Andrew H. Shennan, 2014 Objective To assess the accuracy of the Microlife 3AS1-2 blood pressure device in pregnancy and pre-eclampsia in a low-resource setting. Conclusions The Microlife 3AS1-2 device can be recommended for use in pregnancy, including preeclampsia. In addition, it fulfils the requirements stipulated by the WHO for an automated blood